Home NDC 0527-4664 Lisdexamfetamine Dimesylate
Product NDC 0527-4664
11-digit product format 005274664
Labeler code 0527
Product ID 0527-4664_164b5658-3c14-44f5-b10a-839909184984
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lisdexamfetamine Dimesylate
Dosage form CAPSULE
Route ORAL
Labeler Lannett Company, LLC
Application ANDA215802
Marketing category ANDA
Marketing start 2023-08-25
Substance LISDEXAMFETAMINE DIMESYLATE
Active strength 40 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215802-001 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 A215802-002 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 A215802-003 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 A215802-004 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 A215802-005 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 A215802-006 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 A215802-007 LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 7 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 154 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-006 LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215802-007 LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-006 LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215802-007 LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-006 LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215802-007 LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-006 LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215802-007 LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-006 LISDEXAMFETAMINE DIMESYLATE 60MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215802-007 LISDEXAMFETAMINE DIMESYLATE 70MG CAPSULE / ORAL AB 2023-08-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215802-001 LISDEXAMFETAMINE DIMESYLATE 10MG CAPSULE / ORAL AB 2023-08-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215802-002 LISDEXAMFETAMINE DIMESYLATE 20MG CAPSULE / ORAL AB 2023-08-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215802-003 LISDEXAMFETAMINE DIMESYLATE 30MG CAPSULE / ORAL AB 2023-08-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215802-004 LISDEXAMFETAMINE DIMESYLATE 40MG CAPSULE / ORAL AB 2023-08-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215802-005 LISDEXAMFETAMINE DIMESYLATE 50MG CAPSULE / ORAL AB 2023-08-25 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 154 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Lisdexamfetamine Dimesylate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LISDEXAMFETAMINE DIMESYLATE 40 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0527-4664-37 Lisdexamfetamine Dimesylate 100 in 1 BOTTLE CAPSULE 100 19
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0527-4664 LISDEXAMFETAMINE DIMESYLATE CAPSULE [LANNETT COMPANY, INC.] 17 Current NDC, 1 package rows 20231110_2cedb4c2-1e40-4bc4-b9f4-127150c4afbd.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0527-4664-37 00527466437 100 CAPSULE in 1 BOTTLE (0527-4664-37) 100 capsule 2023-08-25 No No Current